Results

Total Results: 1,547 records

Showing results for "drugs".

141. Crosson JC et al. 2007 "Variation in electronic prescribing implementation among twelve ambulatory practices." | Digital Healthcare Research
     digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/crosson-jc
     January 01, 2023 - program and thought this could undermine their clinical authority as they prefer to write for brand name drugs

142. Surveillance for Adverse Drug Events in Ambulatory Pediatrics (pdf file)
     digital.ahrq.gov/sites/default/files/docs/publication/r18hs017010-bailey-final-report-2011.pdf
     January 01, 2011 - Background and Significance ADEs, defined as harm to patients by drugs,(8) comprise one of the largest … The range of possible ADE types and offending drugs is therefore potentially greater in pediatrics than … , pediatric ADEs may more commonly involve electrolyte solutions, antiinfectives, immunomodulating drugs … proportion of ADEs due to electrolyte-wasting medications (diuretics, antimicrobials, antirejection drugs … Validation of automated event triggers using laboratory values related to two problem-prone drugs.

143. Shareable, Interoperable Clinical Decision Support for Older Adults: Advancing Fall Assessment and Prevention Patient-Centered Outcomes Research Findings into Diverse Primary Care Practices (ASPIRE) - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/u18hs027557-dykes-final-report-2022.pdf
     January 01, 2022 - project team identified three fall injury risk factors (mobility limitations, fall risk increasing drugs … Recommendations were grouped by risk factor with exercise first, fall risk increasing drugs (FRIDS) … In the medication section all recommendations were based on the class of medication the drugs selected … FRIDS tailored deprescription resources N/A because deprescribing was not used 0 some drugs did … /primary-care-management-guidance-fall-risk- increasing-drugs Bibliography: 1.

144. A prospective controlled trial of computerized decision support for lipid management in primary care | AHRQ Digital Healthcare Research: Informing Improvement in Care Quality, Safety, and Efficiency
     digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/prospective-controlled-trial
     April 01, 1996 - There were no differences in the cost of lipid lowering drugs prescribed between the intervention and

145. Value of New Drug Labeling Knowledge for e-Prescribing (pdf file)
     digital.ahrq.gov/sites/default/files/docs/activity/value_of_new_drug_labeling_2009_update_2.pdf
     January 01, 2009 - vendor and product-centric labels; while SPL labels still cover only 23 percent of RxNorm clinical drugs … This is shown best by the ability to use the SPL labels and their descriptions of drugs directly for

146. Ross S et al. 2005 "Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data." | Digital Healthcare Research
     digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/ross-s-et-al-2005
     January 01, 2005 - Ten of the most prescribed categories of drugs were assessed....

147. MEDICATION MANAGEMENT USING HEALTH IT FOR THE CARE OF ELDERLY PATIENTS (pdf file)
     digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-transcript-081811.pdf
     May 25, 2016 - For some drugs it wasn’t the dose that was the issue, it was the frequency with which drugs were being … The third set of recommendations were for drugs which at particularly low levels of renal insufficiency … were quite a few attempts during the course of the year that we tracked to actually try to order drugs … taking; recommendations about dosing issues; and recommendations about lab monitoring of the new drugs … And that’s a dangerous assumption because then why would you tell your physician about your drugs taken

148. Normalizing RxNorm: Experiences using medication information standards for data integration (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/2006RaynerGorman_051911comp.pdf
     May 25, 2011 - • RxNorm • part of UMLS Metathesaurus • designated as nomenclature standard for clinical drugs • under

149. Rotich JK et al. 2003 "Installing and implementing a computer-based patient record system in sub-Saharan Africa: the Mosoriot Medical Record System." | Digital Healthcare Research
     digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/rotich-jk-et-al-2003
     January 01, 2003 - The authors present a summary of the clinics visited, diagnoses made, drugs prescribed, and tests performed

150. Customizing Value-based Methods to Prioritize Implementation of Pharmacogenomic Clinical Decision Support for Learning Health Systems - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/r21hs026544-devine-final-report-2022.pdf
     January 01, 2022 - Pharmacogenomics Implementation Consortium (CPIC) has published 25 guidelines for 20 pharmacogenes and 61 drugs … were modeled separately, and thus the same patient would not trigger multiple alerts for multiple drugs … Incorporation of alerts fired for refills and the possibility that the same patient may require multiple drugs … beyond the scope for the current application development, including: the addition of more genes and drugs … were commonly dispensed in practice.5This evidence suggests that incorporating a broad list of genes, drugs

151. Automated Adverse Drug Event Detection and Intervention (pdf file)
     digital.ahrq.gov/sites/default/files/docs/activity/automated_adverse_drug_event_detection_and_intervention_2009_update_2.pdf
     January 01, 2009 - The primary drugs that generated ADEs in this specialized patient population were assessed, and recommendations

152. Standards | Digital Healthcare Research
     digital.ahrq.gov/standards-0
     January 01, 2023 - The FDA maintains the National Drug Code (NDC) Directory, the universal set of all drugs manufactured … The study found that SPL labels currently contain only a fraction of RxNorm clinical drugs, but they

153. Overriding drug-drug interaction alerts in clinical decision support systems: A scoping review. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/overriding
     January 01, 2023 - Overriding drug-drug interaction alerts in clinical decision support systems: A scoping review. Citation Villa Zapata L, Subbian V, Boyce RD, Hansten PD, Horn JR, Gephart SM, Romero A, Malone DC. Overriding drug-drug interaction alerts in clinical decision support systems: A scoping review. Stud Healt…

154. Improving the Safety of Medication Use in the Long-term Care Setting: Potential Impact of Computerized Clinical Decision Support (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/2006FieldJudgeDeFlorio_051211comp.pdf
     January 01, 2006 - insufficiency  Hypokalemia  Hyperkalemia  Drug dose recommendations  Hyperglycemia  Multiple drugs

155. Impact of Health Information Technology on Clinical Care for Patients with Chronic Medical Conditions (pdf file)
     digital.ahrq.gov/sites/default/files/docs/publication/r01hs015280-hsu-final-report-2008.pdf
     January 01, 2008 - Among diabetic patients receiving diabetes drugs in 2004, 87.6% had ≥ 1 HbA1c test during the year and … Among those with a HbA1c test in 2004: 10.6% did not receive any drugs in the 90 days before their test … Additionally, 50.5% received drugs in one, 30.7% in two, and 8.3% in three or more classes of diabetes … drugs. … Among subjects on any regimen, the mean proportion of days covered by any lipid drugs was 90.8%; among

156. Health Information Technology Center for Education and Research on Therapeutics - 2011 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/annual-summary/2011
     January 01, 2011 - initiative to conduct research and provide education that advances the optimal use of therapeutics (i.e., drugs

157. E-prescribing Impact on Patient Safety, Use and Cost (pdf file)
     digital.ahrq.gov/sites/default/files/docs/publication/r01hs015175-weissman-final-report-2007.pdf
     January 01, 2007 - the new technology increase their use of generic drug equivalents, prescribe a higher proportion of drugs … found on the formulary, and decrease the cost of drugs per prescription? … Since we have only data on drugs that were dispensed, we can only evaluate potential DDIs, we cannot … determine whether actual events occurred or whether patients were actually taking the two drugs at … The proportion of drugs in Tier 2 and Tier 3 (brand medications) decreased correspondingly.

158. Health IT Evaluation Toolkit and Evaluation Measures Quick Reference Guides | Digital Healthcare Research
     digital.ahrq.gov/health-it-evaluation-toolkit
     January 01, 2023 - Prescribing Patterns of Cost-Effective Drugs ( PDF , 94 KB): Evaluating the costs of prescription drug

159. Health Information Technology Center for Education and Research on Therapeutics | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics
     January 01, 2023 - initiative to conduct research and provide education that advances the optimal use of therapeutics including drugs … , Electronic Health Record/Electronic Medical Record , Voice Recognition Use of hepatotoxic drugs … Use of hepatotoxic drugs in chronic liver disease. J Patient Saf 2012 Jun;8(2):45-50.

160. Health Information Technology and Improving Medication Use | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/health-information-technology-and-improving-medication-use
     January 01, 2023 - Patient Reports of Side Effects with Electronic Health Records for Surveillance of Recently Approved Drugs … Information Exchange , Voice Recognition Preventability of adverse drug events involving multiple drugs … Preventability of adverse drug events involving multiple drugs using publicly available clinical decision